Citius Oncology Inc.CTORNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank25
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-21.74M
↓ 40% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-15.58M
Historical baseline
PeriodValueYoY Change
TTM$-21.74M+7.4%
2025$-23.49M-14.2%
2024$-20.57M-69.7%
2023$-12.12M-
2022$0.00-